GC Kahn

1.0k total citations
20 papers, 892 citations indexed

About

GC Kahn is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, GC Kahn has authored 20 papers receiving a total of 892 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 7 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in GC Kahn's work include Pharmacogenetics and Drug Metabolism (13 papers), Cancer Treatment and Pharmacology (4 papers) and Plant-based Medicinal Research (4 papers). GC Kahn is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Cancer Treatment and Pharmacology (4 papers) and Plant-based Medicinal Research (4 papers). GC Kahn collaborates with scholars based in United Kingdom, United States and Philippines. GC Kahn's co-authors include Alan R. Boobis, MJ Brodie, DS Davies, Sandra Murray, C. T. Dollery, M.R. Bending, D. S. Davies, Martin J. Brodie, Donald S. Davies and Eugene Eisenberg and has published in prestigious journals such as Cancer Research, Analytical Biochemistry and Biochemical Pharmacology.

In The Last Decade

GC Kahn

18 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
GC Kahn United Kingdom 15 529 248 178 126 120 20 892
D. S. Davies United Kingdom 19 676 1.3× 336 1.4× 323 1.8× 129 1.0× 137 1.1× 38 1.3k
C B McAllister United States 12 682 1.3× 321 1.3× 232 1.3× 208 1.7× 135 1.1× 15 1.2k
DS Davies United Kingdom 18 827 1.6× 384 1.5× 266 1.5× 169 1.3× 172 1.4× 33 1.4k
P J Wedlund United States 19 737 1.4× 336 1.4× 267 1.5× 250 2.0× 137 1.1× 31 1.2k
H Echizen Japan 14 385 0.7× 248 1.0× 148 0.8× 155 1.2× 117 1.0× 30 777
G. Thomas Passananti United States 19 401 0.8× 147 0.6× 206 1.2× 172 1.4× 185 1.5× 39 1.1k
T. Leemann Switzerland 16 871 1.6× 415 1.7× 219 1.2× 159 1.3× 267 2.2× 26 1.3k
Leif Bertilsson Sweden 10 607 1.1× 267 1.1× 128 0.7× 140 1.1× 145 1.2× 11 933
P Bechtel France 15 495 0.9× 201 0.8× 177 1.0× 110 0.9× 198 1.6× 55 935
P J Meffin Australia 24 364 0.7× 138 0.6× 174 1.0× 78 0.6× 274 2.3× 38 1.2k

Countries citing papers authored by GC Kahn

Since Specialization
Citations

This map shows the geographic impact of GC Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by GC Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites GC Kahn more than expected).

Fields of papers citing papers by GC Kahn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by GC Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by GC Kahn. The network helps show where GC Kahn may publish in the future.

Co-authorship network of co-authors of GC Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of GC Kahn. A scholar is included among the top collaborators of GC Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with GC Kahn. GC Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schram, Alison M., GC Kahn, Richard Kinh Gian, et al.. (2025). Abstract 1151: NRG1 fusion-positive solid tumors: clinical detection, genomic landscape, and real-world data in PDAC. Cancer Research. 85(8_Supplement_1). 1151–1151.
2.
Eisenberg, Eugene, et al.. (1989). High-performance liquid chromatographic method for the simultaneous determination of the enantiomers of carvedilol and its O-desmethyl metabolite in human plasma after chiral derivatization. Journal of Chromatography B Biomedical Sciences and Applications. 493(1). 105–115. 60 indexed citations
3.
Kahn, GC, Marc Rubenfield, D. S. Davies, & Alan R. Boobis. (1987). PhenacetinO-deethylase activity of the rat: strain differences and the effects of enzyme-inducing compounds. Xenobiotica. 17(2). 179–187. 9 indexed citations
4.
Kahn, GC, Yi‐Ju Li, & Michael D. Kane. (1986). Routine Monitoring of Cyclosporine in Whole Blood and in Kidney Tissue Using High Performance Liquid Chromatography. Journal of Analytical Toxicology. 10(1). 28–34. 30 indexed citations
5.
Kahn, GC, et al.. (1985). Phenacetin O‐deethylase: an activity of a cytochrome P‐450 showing genetic linkage with that catalysing the 4‐hydroxylation of debrisoquine?. British Journal of Clinical Pharmacology. 20(1). 67–76. 31 indexed citations
6.
Kahn, GC, Marc Rubenfield, D. S. Davies, Scott A Murray, & Alan R. Boobis. (1985). Sex and strain differences in hepatic debrisoquine 4-hydroxylase activity of the rat.. Drug Metabolism and Disposition. 13(4). 510–516. 49 indexed citations
7.
Boobis, Alan R., et al.. (1983). Substrate specificity of the form of cytochrome P-450 catalyzing the 4-hydroxylation of debrisoquine in man.. Molecular Pharmacology. 23(2). 474–481. 59 indexed citations
8.
Kahn, GC, Alan R. Boobis, Sandra Murray, & D. S. Davies. (1982). Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrinein vitroby microsomal fractions of rat liver. Xenobiotica. 12(8). 509–516. 27 indexed citations
9.
Kahn, GC, Alan R. Boobis, Sandra Murray, MJ Brodie, & DS Davies. (1982). Assay and characterisation of debrisoquine 4‐hydroxylase activity of microsomal fractions of human liver.. British Journal of Clinical Pharmacology. 13(5). 637–645. 56 indexed citations
10.
Boobis, Alan R., et al.. (1981). Biphasic O-deethylation of phenacetin and 7-ethoxycoumarin by human and rat liver microsomal fractions. Biochemical Pharmacology. 30(17). 2451–2456. 78 indexed citations
11.
Kahn, GC, Alan R. Boobis, Ian A. Blair, Martin J. Brodie, & Donald S. Davies. (1981). A radiometric high-pressure liquid chromatography assay for the simultaneous determination of the three main oxidative metabolites of antipyrine in studies in vitro. Analytical Biochemistry. 113(2). 292–300. 14 indexed citations
12.
Boobis, Alan R., et al.. (1981). Comparison of the in vivo and in vitro rates of formation of the three main oxidative metabolites of antipyrine in man.. British Journal of Clinical Pharmacology. 12(6). 771–777. 62 indexed citations
13.
Davies, DS, GC Kahn, Sandra Murray, MJ Brodie, & Alan R. Boobis. (1981). Evidence for an enzymatic defect in the 4‐hydroxylation of debrisoquine by human liver.. British Journal of Clinical Pharmacology. 11(1). 89–91. 80 indexed citations
14.
Benford, Diane, James Winfred Bridges, Alan R. Boobis, et al.. (1981). The selective activation of cytochrome P-450 dependent microsomal hydroxylases in human and rat liver microsomes. Biochemical Pharmacology. 30(12). 1702–1703. 15 indexed citations
15.
McManus, Michael E., et al.. (1980). Xenobiotic metabolism in the human lung. Life Sciences. 26(6). 481–487. 35 indexed citations
16.
Boobis, Alan R., et al.. (1980). Monooxygenase activity of human liver in microsomal fractions of needle biopsy specimens.. British Journal of Clinical Pharmacology. 9(1). 11–19. 136 indexed citations
17.
Kahn, GC, et al.. (1980). Antipyrine as an in vitro probe of mixed function oxidase activity [proceeding]. British Journal of Clinical Pharmacology. 9(3). 284P–284P. 14 indexed citations
18.
Boobis, Alan R., et al.. (1979). Biphasic Michaelis-Menten kinetics for ethoxycoumarin and phenacetin metabolism by human and rat hepatic monooxygenases [proceedings].. PubMed. 66(3). 428P–428P. 1 indexed citations
19.
Bending, M.R., et al.. (1978). Drug concentration in saliva. Clinical Pharmacology & Therapeutics. 24(5). 563–570. 129 indexed citations
20.
Kahn, GC, et al.. (1971). A comparison of dermal sensitivity to preservative and local anesthetic drugs.. PubMed. 29(9). 480–2. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026